Congratulations to Dr Shrianee Sriskandan, who has been awarded funding as part of UK investment in biosecurity research. The project, CARMA, will explore how environmental changes may drive antimicrobial resistance.🔬 www.imperial.ac.uk/news/article...
Department of Infectious Disease
@imperialinfect.bsky.social
Department of Infectious Disease at Imperial College London | Part of the Faculty of Medicine | Innovating new approaches to infectious disease control on a global scale https://www.imperial.ac.uk/infectious-disease/
Don't forget to join our next seminar with Prof George Chamilos. He will discuss the mechanisms regulating fungal phagosome biogenesis in health and disease. 📅 6 October 2026 ⏰ 13:00–14:00 📍 South Kensington / Online www.imperial.ac.uk/events/20980...
The first-in-human rabies vaccine study is now underway. The trial assesses a next-generation RNA rabies vaccine that could strengthen future pandemic preparedness.👇️ www.imperial.ac.uk/news/article...
First participants vaccinated in Imperial rabies vaccine trial
Researchers have launched the first in-human study of a rabies vaccine that could improve global access to protection against rabies while helping ad...
imperial.ac.uk
How do we prepare for the next biosecurity threat? From AI-enabled pathogen design to detecting outbreaks through wastewater, Imperial experts say collaboration, innovation, and responsible AI are key to keeping the world safer. www.imperial.ac.uk/news/article...
AI, pandemics and food security: Imperial experts discuss the future of biosecurity
From the potential for AI designed viruses, to detecting threats in our wastewater and protecting our food networks, biosecurity is becoming an incre...
imperial.ac.uk
Our Prof Darius Armstrong-James is playing a key role in the new Wellcome-funded MycoDTP. The collaboration aims to develop future leaders in fungal disease research.👇️ www.citystgeorges.ac.uk/news-and-eve...
City St George's to lead pioneering doctoral programmes tackling global fungal threat and underrepresented populations disease research | City St George's, University of London
Wellcome-funded Clinical Doctoral Training Programmes at City St George’s are supporting students to carry out research into overlooked fungal diseases and diseases affecting marginalised populations
citystgeorges.ac.uk
Our department seminar series is back! Join us for our next seminar with Prof George Chamilos. He will discuss the mechanisms regulating fungal phagosome biogenesis in health and disease. 📅 6 October 2026 ⏰ 13:00–14:00 📍 South Kensington / Online www.imperial.ac.uk/events/20980...
New research reveals persistent inequalities in NHS speciality training recruitment. Analysis of data from 2021-2024 found lower success rates for doctors who are pregnant or on maternity leave, and UK-trained doctors from ethnic minority backgrounds.👇️ www.imperial.ac.uk/news/article...
Study reveals persistent inequalities in NHS speciality training recruitment
New research shows that there are persistent disparities when recruiting doctors into NHS speciality training programmes, with lower success rates fo...
imperial.ac.uk
We're approaching a powerful point of "convergence of automation, data and machine learning and AI." Prof Paul Freemont highlights how AI is transforming automated biolabs and accelerating discovery in synthetic biology. Read more in @knowablemag.bsky.social.👇️ knowablemagazine.org/content/arti...
Artificial intelligence boosts automated biolabs
AI and machine learning are kicking synthetic biology up to new levels of innovation. Researchers see huge potential for novel drugs and other chemicals; some also see risks.
knowablemagazine.org
How does the immune system keep up with an ever-changing viral world? 🦠 In @nature.com, Prof Rosemary Boyton & @daltmann.bsky.social explore how SARS-CoV-2 research revealed that optimal protection balances immune memory with new variant-specific antibodies. www.nature.com/articles/s41...
Immune imprinting in a changing world - Nature Immunology
Research on SARS-CoV-2 shows that effective immunity can arise from a balance between recalling existing immune memory and generating new variant-specific antibodies, with important implications for…
nature.com
New research could help stop flu before it spreads. @racheledgar.bsky.social & @anikasinga.bsky.social have been awarded £1.3m by @TheFluLab to explore whether glycol-based air treatments can reduce airborne virus transmission of flu and other airborne diseases. www.imperial.ac.uk/news/article...
£1.3m awarded to Imperial team investigating new approach to stop flu transmission
The funding from Flu Lab will be used to explore new ways to stop flu spreading through the air.
imperial.ac.uk
Rabies is preventable, yet it still claims thousands of lives each year. Current vaccines can be difficult to access and require multiple doses. In this blog, Dr Maithili Varadarajan explains how a new RNA-based rabies vaccine could help change this.👇️ blogs.imperial.ac.uk/imperial-med...
Why do we need new vaccines for rabies? - Imperial Medicine Blog
Rabies remains one of the most recognised zoonotic infections worldwide and continues to cause significant loss of life despite being entirely preventable. In this post Dr Maithili Varadarajan, from…
blogs.imperial.ac.uk
🚨 New Research Associate opportunity! Join the Edgar & Singanayagam labs to investigate how glycol vapour can prevent flu transmission and help protect against future pandemics. 💰£50,733+, full-time 📌South Kensington campus ✍️Apply by 25 Aug www.imperial.ac.uk/jobs/search-...
Description
Please note that job descriptions are not exhaustive, and you may be asked to take on additional duties that align with the key responsibilities ment...
imperial.ac.uk
New paper 📄 out in @embomolmed.org: We show that the Slr protein of S. pyogenes is a target of protective antibodies and present evidence that it is selectively expressed in vivo. Link: pubmed.ncbi.nlm.nih.gov/42298213/
The Slr protein of Streptococcus pyogenes is selectively expressed in vivo and is a target for protective antibodies - PubMed
Vaccine candidates are typically identified through characterization of microbial surface antigens expressed under laboratory conditions. Here, we studied the major human pathogen Streptococcus pyogen...
pubmed.ncbi.nlm.nih.gov
The body's earliest immune response may determine whether people will develop flu symptoms. 🤧 Using a controlled human challenge study, researchers were able to build a picture of how immune responses unfold in the initial days after exposure to the virus.👇️ www.imperial.ac.uk/news/article...
Early immune response may determine who gets flu symptoms, study finds
Using human challenge studies, research reveals that a stronger early immune response can drive both the symptoms of infection and viral clearance.
imperial.ac.uk
Don't forget to join us tomorrow for our seminar with Prof Charlotte Uetrecht (University of Lübeck, Hamburg). Her talk is titled 'Flying viruses: mass spectrometry meets X-rays'. 📅 7 July 2026 ⏰ 13:00–14:00 📍 South Kensington / Online www.imperial.ac.uk/events/20980...
Imperial has secured £12.7m from ARIA to protect people against respiratory viruses. As part of a Sustained Viral Resilience programme, our teams will work to develop a new class of medicines to provide durable, wide-ranging protection against respiratory viruses. www.imperial.ac.uk/news/article...
Imperial secures £12.7m from ARIA to develop broad protection against respiratory viruses
Imperial researchers have secured £12.7 million in funding from the UK’s Advanced Research and Invention Agency (ARIA), to develop new wa...
imperial.ac.uk
Join us for our next seminar with Prof Charlotte Uetrecht (University of Lübeck, Hamburg). The talk is titled 'Flying viruses: mass spectrometry meets X-rays'. 📅 7 July 2026 ⏰ 13:00–14:00 📍 South Kensington / Online www.imperial.ac.uk/events/20980...
Dr Aran Singanayagam has been named a 2026 Lister Prize Fellow @thelisterinstitute.bsky.social. 🎉 Securing £300k to advance vital research into the lung microbiome, his work explores how respiratory microbes shape health and disease. #ListerPrize2026
Imperial researcher wins prestigious Lister Prize 2026
Dr Aran Singanayagam in the Department of Infectious Disease has been named a 2026 Lister Prize fellow, securing £300,000 in funding to advance...
imperial.ac.uk
Join us on 30 June for a seminar with Prof John Briggs (Max Planck Institute). Discover his cutting-edge research on “in situ” structural biology of HIV-1 & Influenza. 📅 30 June 2026 ⏰ 13:00–14:00 📍 South Kensington / Online www.imperial.ac.uk/events/20364...
Are beards unhygienic? 🧔♂️ Not according to the evidence. As Prof John Tregoning explains, all skin, bearded or clean‑shaven, harbours bacteria.👇️ www.theguardian.com/lifeandstyle...
Is it true that … beards are unhygienic?
People assume that those with facial hair are more likely to harbour bacteria on their faces than the clean-shaven – but the truth is more tangled
theguardian.com
First in the UK, second in the world! We’ve retained our QS World University Ranking for the third year in a row! 🎉 This success is thanks to every single member of Imperial’s community, as we work together to make a meaningful difference in the world.
What can we learn from the recent #MeningitisB outbreak? Prof Shiranee Sriskandan & Prof Mariagrazia Pizza unpack the science and highlight why vaccination is crucial. #PublicHealth Read more in this Q&A👇️ www.imperial.ac.uk/news/article...
Meningitis Q&A: learning from history and solutions for the future
In this interview we discuss the recent Meningitis B outbreak with experts Professor Mariagrazia Pizza, Chair in Microbiology and Professor Shiranee...
imperial.ac.uk
New research shows that flu infection may increase susceptibility to tuberculosis (TB) by weakening key immune pathways. The findings suggest seasonal flu vaccines could offer a new tool to help prevent TB in high-risk regions. 💉 👇️ www.imperial.ac.uk/news/article...
Flu infection may leave people more susceptible to tuberculosis infection, study suggests
New research from Imperial College London suggests that infection with the influenza virus may leave people more susceptible to tuberculosis.
imperial.ac.uk
Researchers CBRB welcomed colleagues from WACCBIP as part of an Imperial Global Connect visit. The event aimed to strengthen international partnerships and advance discovery research in bacterial antimicrobial resistance (AMR). 🔬 www.imperial.ac.uk/news/article...
Join us on 30 June for a seminar with Prof John Briggs (Max Planck Institute). Discover his cutting-edge research on “in situ” structural biology of HIV-1 & Influenza. 📅 30 June 2026 ⏰ 13:00–14:00 📍 South Kensington / Online www.imperial.ac.uk/events/20364...
A new HIV treatment could let people safely pause daily medication.💊 The @riotrial.bsky.social found that immune-based therapy enabled 75% of participants to stop ART for 20 weeks, potentially offering a longer-lasting alternative treatment.👇 www.imperial.ac.uk/news/article...
New HIV treatment could enable people to safely stop daily medication
A major clinical trial has shown that an immune-based treatment allows people living with HIV to safely stop daily therapy and could offer a longer-a...
imperial.ac.uk
Congratulations to Prof Michael Way on being elected a Fellow of the Royal Society 🎉 Professor @imperialcollegeldn.bsky.social and group leader @crick.ac.uk, his work has shaped a wider understanding of cell signalling and host-pathogen interactions. www.crick.ac.uk/news/2026-05...
Congratulations to Prof Paul Kellam on his election to the @acmedsci.bsky.social Fellowship 👏 A leader in virus genomics, his work on viral evolution, pathogen genomics and antiviral immunity has shaped global responses to outbreaks. 👉 imperial.ac.uk/news/article...
Antibiotics are losing their effectiveness, and routine treatments could become impossible. Featuring work from our Dr Tim Rawson and Dr Andy Edwards, this @nature.com video explores the threat of antimicrobial resistance and the race for solutions. Watch now👇 www.youtube.com/watch?v=B5zB...
The scientists fighting to stop the antibiotic apocalypse
YouTube video by nature video
youtube.com
Could a simple blood test predict how an illness will unfold?🩸 Scientists at @imperialinfect.bsky.social have developed VeloCD, a method that can forecast disease progression and treatment response — with potential to transform patient care. 🔽 www.imperial.ac.uk/news/article...
Blood test could help predict disease progression and how well treatment will work
Scientists are developing a test which could one day be used to predict how a patient’s illness will progress, and even how well they will resp...
imperial.ac.uk